Nahmias Jeffry, Grigorian Areg, Brakenridge Scott, Jawa Randeep S, Holena Daniel N, Agapian John Varujan, Bruns Brandon, Chestovich Paul J, Chung Bruce, Nguyen Jonathan, Schulman Carl I, Staudenmayer Kristan, Dixon Rachel, Smith Jason W, Bernard Andrew C, Pascual Jose L
Department of Surgery, University of California, Irvine, California, USA.
Department of Surgery, University of Florida Health Science Center, Gainesville, Florida, USA.
Trauma Surg Acute Care Open. 2018 May 30;3(1):e000176. doi: 10.1136/tsaco-2018-000176. eCollection 2018.
Oversight of human subject research has evolved considerably since its inception. However, previous studies identified a lack of consistency of institutional review board (IRB) determination for the type of review required and whether informed consent is necessary, especially for prospective observational studies, which pose minimal risk of harm. We hypothesized that there is significant inter-institution variation in IRB requirements for the type of review and necessity of informed consent, especially for prospective observational trials without blood/tissue utilization. We also sought to describe investigators' and IRB members' attitudes toward the type of review and need for consent. Eastern Association for the Surgery of Trauma (EAST) and IRB members were sent an electronic survey on IRB review and informed consent requirement. We performed descriptive analyses as well as Fisher's exact test to determine differences between EAST and IRB members' responses. The response rate for EAST members from 113 institutions was 13.5%, whereas a convenience sample of IRB members from 14 institutions had a response rate of 64.4%. Requirement for full IRB review for retrospective studies using patient identifiers was reported by zero IRB member compared with 13.1% of EAST members (p=0.05). Regarding prospective observational trials without blood/tissue collection, 48.1% of EAST members reported their institutions required a full IRB review compared with 9.5% of IRB members (p=0.01). For prospective observational trials with blood/tissue collection, 80% of EAST members indicated requirement to submit a full IRB review compared with only 13.6% of IRB members (p<0.001). Most EAST members (78.6%) stated that informed consent is not ethically necessary in prospective observational trials without blood/tissue collection, whereas most IRB members thought that informed consent was ethically necessary (63.6%, p<0.001). There is significant variation in perception and practice regarding the level of review for prospective observational studies and whether informed consent is necessary. We recommend future interdisciplinary efforts between researchers and IRBs should occur to better standardize local IRB efforts.
IV.
自人体研究监督工作开展以来,其已发生了显著演变。然而,先前的研究发现,机构审查委员会(IRB)在确定所需审查类型以及知情同意是否必要方面缺乏一致性,尤其是对于危害风险极小的前瞻性观察性研究。我们假设,IRB在审查类型要求和知情同意必要性方面存在显著的机构间差异,尤其是对于不涉及血液/组织利用的前瞻性观察性试验。我们还试图描述研究人员和IRB成员对审查类型和同意必要性的态度。向东区创伤外科学会(EAST)成员和IRB成员发送了一份关于IRB审查和知情同意要求的电子调查问卷。我们进行了描述性分析以及Fisher精确检验,以确定EAST成员和IRB成员的回答之间的差异。来自113个机构的EAST成员的回复率为13.5%,而来自14个机构的IRB成员的便利样本的回复率为64.4%。与13.1%的EAST成员相比,零IRB成员报告对使用患者标识符的回顾性研究需要进行全面IRB审查(p = 0.05)。对于不涉及血液/组织采集的前瞻性观察性试验,48.1%的EAST成员报告其所在机构要求进行全面IRB审查,而IRB成员中这一比例为9.5%(p = 0.01)。对于涉及血液/组织采集的前瞻性观察性试验,80%的EAST成员表示需要提交全面IRB审查,而IRB成员中这一比例仅为13.6%(p < 0.001)。大多数EAST成员(78.6%)表示,在不涉及血液/组织采集的前瞻性观察性试验中,从伦理角度讲不需要知情同意,而大多数IRB成员认为从伦理角度讲知情同意是必要的(63.6%,p < 0.001)。在前瞻性观察性研究的审查水平以及知情同意是否必要方面,存在显著的认知和实践差异。我们建议研究人员和IRB未来应开展跨学科合作,以更好地规范当地IRB的工作。
IV级。